The synthesis of the pyrrolo[2,1-a]phthalazine derivatives was performed by an efficient one-pot three-component reaction starting from phthalazine, 2-bromoacetophenones and nonsymmetrical and symmetrical acetylenicdipolarophiles in 1,2-epoxybutane as both reaction medium and HBr scavenger. The structure of the compounds was assigned by IR and NMR spectroscopy.
A formal [3 + 2] annulation reaction of propargyl sulfonium compounds and <i>N</i>-ylides: access to pyrrolo[2,1-<i>a</i>]quinolines, pyrrolo[2,1-<i>a</i>]phthalazines and indolizines
作者:Jing Zheng、Xiaojie He、Hong Xu、Hua Liu、Weiran Yang
DOI:10.1039/d0ob01739f
日期:——
A sequential [3 + 2] annulation of prop-2-ynylsulfonium salt and N-ylides was developed, leading to the formation of a series of pyrrolo[2,1-a]quinolines, pyrrolo[2,1-a]phthalazines and indolizines. The protocol featured the simultaneous one-pot formation of three new C–C bonds in moderate yields under mild conditions. In this reaction, the prop-2-ynylsulfonium salts acted as the C2 synthons and sulfide
开发了丙-2-炔基锍盐和N-叶立德的顺序[3 + 2]环化,导致形成一系列吡咯并[2,1 - a ]喹啉、吡咯并[2,1 - a ]酞嗪和中氮茚。该协议的特点是在温和条件下以中等收益率同时一锅形成三个新的 C-C 键。在该反应中,prop-2-ynyl 锍盐充当 C2 合成子,硫化物充当离去基团。所得产物可作为合成多种化合物的有用前体。
Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides
作者:Samuel J. Dominianni、Terence T. Yen
DOI:10.1021/jm00130a013
日期:1989.10
Blood glucose levels in viable, yellow, obese, diabetic mice are reduced following oral administration of phenacylimidazolium halides. Compounds 2 and 3 produced reductions of ca. 40% 2 h after doses of 100 mg/kg po. Since these mice do not respond to sulfonylureas, the glucose-lowering activity of phenacylimidazolium salts in this model suggests a mechanism other than that of stimulating insulin secretion. Only phenacylimidazolium halides with electron-donating groups were active; other azolium salts or variations in the phenacyl portion (alterations in the keto function; chain lengthening or extensive branching) produced inactive compounds.